The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

"Schizophrenia is a leading cause of disability worldwide ... People "are a little wary of claims before they actually see ...

Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

MORE: Mom who struggled to accept her son's schizophrenia talks about crisis services The first drugs for schizophrenia, including chlorpromazine and haloperidol – also known by the brand names ...